Hello Heart

Validation Institute Independently Certifies that Hello Heart Delivers a $1,865 Per Participant Per Year Reduction in Total Medical Claims

Retrieved on: 
Wednesday, January 26, 2022

The distinction confirms that Hello Hearts AI-driven, smartphone-based solution reduced total employer medical spend by an average of $1,865 per participant per year.

Key Points: 
  • The distinction confirms that Hello Hearts AI-driven, smartphone-based solution reduced total employer medical spend by an average of $1,865 per participant per year.
  • The substantial cost savings of $1,865 per participant per year or 19% of total medical claims spending is largely the result of participants avoiding expensive surgeries and invasive procedures.
  • When comparing Hello Heart participants to matched control members, some notable reductions in spending by service category include:
    The study also found that Hello Heart program participants increased their visits to primary care providers, as the Hello Heart solution encourages use of preventative care.
  • Hello Heart is the only digital therapeutics company to focus exclusively on heart disease, the leading cause of death worldwide.

Hello Heart Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups

Retrieved on: 
Tuesday, December 21, 2021

CB Insights today named Hello Heart to its third annual Digital Health 150 , which showcases the 150 most promising private digital health companies in the world.

Key Points: 
  • CB Insights today named Hello Heart to its third annual Digital Health 150 , which showcases the 150 most promising private digital health companies in the world.
  • This years Digital Health 150 was unveiled live during CB Insights annual Future of Health event.
  • Companies this year include startups working on data integration & analytics, hybrid virtual / in-person care, digital therapeutics, clinical intelligence, and more.
  • Through an evidence-based approach, the CB Insights research team selected the Digital Health 150 from a pool of over 11,000 companies, including applicants and nominees.

Hello Heart Completes $45M Investment to Fuel Growth and Expand Digital Heart Health

Retrieved on: 
Wednesday, May 26, 2021

Hello Heart , the best-in-class heart health digital therapeutics solution, has completed a $45 million Series C led by IVP.

Key Points: 
  • Hello Heart , the best-in-class heart health digital therapeutics solution, has completed a $45 million Series C led by IVP.
  • Hello Hearts mission is to empower people to manage and improve their heart health using digital technology.
  • Hello Heart is the only digital therapeutic hypertension solution with a peer-reviewed clinical study on blood pressure outcomes.
  • Hello Heart has an opportunity to become the digital therapeutics leader for all cardiovascular diseases and were excited to partner with them on their growth phase.